Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
September 1, 1994
[Bilateral varicocele: diagnostic implications]
V Mirone, A Palmieri
Advances in Experimental Medicine and Biology
|
January 1, 1991
Testicular hyperthermia: physiopathology, diagnostic and therapeutical concepts
V Mirone, F Iacono
British Journal of Urology
|
March 1, 1993
Intracavernous cyclic GMP produces penile erection in patients with erectile dysfunction
V Mirone, A Palmieri, G Nisticò
Panminerva Medica
|
March 19, 2014
Renal transplantation: technical aspects, diagnosis and management of early and late urological complications
F Greco, P Fornara, V Mirone
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
December 1, 1996
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy]
D Prezioso, V Mirone, F Fabrizio, et al.
European Urology
|
September 4, 1999
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica
V Mirone, C Imbimbo, A Palmieri, et al.
The Journal of International Medical Research
|
July 1, 1987
Ciprofloxacin in the treatment of urinary tract infections
T Lotti, V Mirone, C Imbimbo, et al.
Minerva Medica
|
April 1, 1996
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]
V Mirone, D Prezioso, A Palmieri, et al.
European Urology
|
January 1, 1984
Mucinous adenocarcinoma of the renal pelvis
V Mirone, D Prezioso, S Palombini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 1, 1988
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy]
V Mirone, D Prezioso, A Palmieri, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
September 1, 1994
[Bilateral varicocele: diagnostic implications]
V Mirone, A Palmieri
Advances in Experimental Medicine and Biology
|
January 1, 1991
Testicular hyperthermia: physiopathology, diagnostic and therapeutical concepts
V Mirone, F Iacono
British Journal of Urology
|
March 1, 1993
Intracavernous cyclic GMP produces penile erection in patients with erectile dysfunction
V Mirone, A Palmieri, G Nisticò
Panminerva Medica
|
March 19, 2014
Renal transplantation: technical aspects, diagnosis and management of early and late urological complications
F Greco, P Fornara, V Mirone
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
December 1, 1996
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy]
D Prezioso, V Mirone, F Fabrizio, et al.
European Urology
|
September 4, 1999
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica
V Mirone, C Imbimbo, A Palmieri, et al.
The Journal of International Medical Research
|
July 1, 1987
Ciprofloxacin in the treatment of urinary tract infections
T Lotti, V Mirone, C Imbimbo, et al.
Minerva Medica
|
April 1, 1996
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]
V Mirone, D Prezioso, A Palmieri, et al.
European Urology
|
January 1, 1984
Mucinous adenocarcinoma of the renal pelvis
V Mirone, D Prezioso, S Palombini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 1, 1988
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy]
V Mirone, D Prezioso, A Palmieri, et al.
Page
of 8